Applications are invited from suitable candidate for filling up the following position at National
Institute of Animal Biotechnology (NIAB), Hyderabad against the DBT-NIH (India-U.S. Collaborative
Research on Vaccine Adjuvant Development) funded project entitled “Development of Novel
Adjuvanted Vaccine for Foot and Mouth Disease”.
PI & Project Co-ordinator: Dr. Syed M. Faisal,
NIAB, Hyderabad, Co-PI: Dr. Aniket Sanyal, IVRI, Bangalore, Co-PI- Dr. Dennis Carson, University of
California, San Diego, USA.
(i) One position of Senior Research Fellow/Project Associate-II
Essential qualifications: Post Graduate Degree in life sciences OR Graduate/Post Graduate degree
in professional course. M.V.Sc./M.Tech./ MSc./M.Pharm Degree in Biotechnology
Biochemistry/ Microbiology/Immunology with first division.
The candidate should have minimum
two-year research experience preferably as JRF (Eligibility criteria as per DST OM No.SR/S9/Z09/2012 dated 21.10.2014 and SR/S9/Z-08/2018 dated 30.01.2019). NET/GATE qualified
candidate will be preferred.
Desirable qualification/Experience: Experience in cell culture, immunological techniques,
Adjuvant chemistry, nanotechnology, preparing adjuvant formulations and animal (mice) handling
is desirable.
Candidates having prior experience in working on vaccine adjuvants or their
mechanism of action will be preferred.
Fellowship amount: Rs.35000/-PM +24% HRA (if applicable) as per the DST guidelines.
Age: 35 years (Relaxation is admissible in case of SC/ST/OBC candidates as per Government
instructions)
Interested candidates fulfilling the above criteria may attend the walk-in interview at the National
Institute of Animal Biotechnology (NIAB), Opp. Journalist Colony, Near Gowlidoddy, Extended Q
City Road, Gachibowli, Hyderabad, Telangana on 18-01-2023 at 10:00 am with a photograph and
copies of documents in support of date of birth, educational qualifications, experience certificates
etc.
Application forms may be filled-in on the spot, and the information provided in the application
must match the testimonials.
Advt. No. 01/2023 – Walk in Interview
0 Comments